alpha-乙基-2-氧代-1-吡咯烷乙酸

2-(2-Oxopyrrolidin-1-yl)butanoic acid

产品编号.: A118314 CAS号: 67118-31-4
分子式: C8H13NO3 分子量: 171.19372
纯度: 98% MDL NO.:

中文名称:alpha-乙基-2-氧代-1-吡咯烷乙酸
CAS号:67118-31-4
中文别名:alpha-乙基-2-氧代-1-吡咯烷乙酸;乙拉西坦羧酸;左乙拉西坦杂质A;左乙拉西坦中间体(LVA20)
英文名称:2-(2-Oxopyrrolidin-1-yl)butanoic acid
英文别名:2-(2-Oxopyrrolidin-1-yl)butanoic acid;Etiracetam Carboxylic Acid;ALPHA-ETHYL-2-OXO-1-PYRROLIDINEACETIC ACID;Ethyl-2-oxo-1-pyrrolidineacetic acid;2-(2-oxo-1-pyrrolidinyl)butyric acid;2-(2-oxopyrrolidin-1-yl)butyric acid;ACMC-209vls;AGN-PC-00CF5M;CTK8B4203;Levetiracetam acid, (+/-)-;SureCN1747843;UNII-T5GZ0UL12V;(2RS)-2-(2-Oxopyrrolidin-1-yl)butanoic acid;2(2oxopyrrolidin1yl)butanamide;alphaEthyl2oxo1pyrrolidineaceticacid;ETHYL2OXO1PYRROLIDINEACETATE;Ethyl(2oxopyrrolidin1yl)acetate;ethyl2(2oxopyrrolidin1yl)acetate;2-(2-oxopyrrolidin-1-yl)butanoic acid;(S)-2-(2-Oxo-1-pyrrolidinyl)butanoic Acid;(+/-)-2-(2-oxopyrrolidin-1-yl)butanoic acid;AB44229;EN300-90324;BCP10279;A835635;racemic alpha-ethyl-2-oxo-1-pyrrolidineacetic acid;AKOS005216477;MFCD08272027;Z425426776;67118-31-4;2-(2-oxopyrrolidin-1-yl) butyric acid;SCHEMBL1747843;alpha.-Ethyl-2-oxo-1-pyrrolidineacetic,acid;(RS)-alpha-ethyl-2-oxo-1-pyrrolidineacetic acid;1-Pyrrolidineacetic acid, alpha-ethyl-2-oxo-;1-PYRROLIDINEACETIC ACID, .ALPHA.-ETHYL-2-OXO-;2-(2-Oxopyrrolidin-1-yl)butanoic acid, (2RS)-;AKOS016842777;B2694-053235;T5GZ0UL12V;Levetiracetam Imp. A (EP); 1-Pyrrolidineacetic acid, alpha-ethyl-2-oxo-; Levetiracetam Impurity A;LEVETIRACETAM IMPURITY A [EP IMPURITY];Q27289698;FT-0674887;(s)-alpha-ethyl-2-oxo-1-pyrrolidineacetic acid;SY318250;Levetiracetam impurity A;Levetiracetam specified impurity A [EP];IODGAONBTQRGGG-UHFFFAOYSA-N;FT-0652183;2-(2-Oxopyrrolidin-1-yl)butanoic acid, (+/-)-;F96498;FT-0600415;(2R)-2-(2-oxo-1-pyrrolidinyl)butanoic acid;DB-022453;STL451037
EINEC:
分子式:C8H13NO3
分子量:171.19372
搜索质检报告(COA)
搜索MSDS
已经到最底了
批量搜索 关闭
批处理可以通过CAS号,CAS号,每行一个搜索
...

alpha-乙基-2-氧代-1-吡咯烷乙酸
2-(2-Oxopyrrolidin-1-yl)butanoic acid;Etiracetam Carboxylic Acid;ALPHA-ETHYL-2-OXO-1-PYRROLIDINEACETIC ACID;Ethyl-2-oxo-1-pyrrolidineacetic acid;2-(2-oxo-1-pyrrolidinyl)butyric acid;2-(2-oxopyrrolidin-1-yl)butyric acid;ACMC-209vls;AGN-PC-00CF5M;CTK8B4203;Levetiracetam acid, (+/-)-;SureCN1747843;UNII-T5GZ0UL12V;(2RS)-2-(2-Oxopyrrolidin-1-yl)butanoic acid;2(2oxopyrrolidin1yl)butanamide;alphaEthyl2oxo1pyrrolidineaceticacid;ETHYL2OXO1PYRROLIDINEACETATE;Ethyl(2oxopyrrolidin1yl)acetate;ethyl2(2oxopyrrolidin1yl)acetate;2-(2-oxopyrrolidin-1-yl)butanoic acid;(S)-2-(2-Oxo-1-pyrrolidinyl)butanoic Acid;(+/-)-2-(2-oxopyrrolidin-1-yl)butanoic acid;AB44229;EN300-90324;BCP10279;A835635;racemic alpha-ethyl-2-oxo-1-pyrrolidineacetic acid;AKOS005216477;MFCD08272027;Z425426776;67118-31-4;2-(2-oxopyrrolidin-1-yl) butyric acid;SCHEMBL1747843;alpha.-Ethyl-2-oxo-1-pyrrolidineacetic,acid;(RS)-alpha-ethyl-2-oxo-1-pyrrolidineacetic acid;1-Pyrrolidineacetic acid, alpha-ethyl-2-oxo-;1-PYRROLIDINEACETIC ACID, .ALPHA.-ETHYL-2-OXO-;2-(2-Oxopyrrolidin-1-yl)butanoic acid, (2RS)-;AKOS016842777;B2694-053235;T5GZ0UL12V;Levetiracetam Imp. A (EP); 1-Pyrrolidineacetic acid, alpha-ethyl-2-oxo-; Levetiracetam Impurity A;LEVETIRACETAM IMPURITY A [EP IMPURITY];Q27289698;FT-0674887;(s)-alpha-ethyl-2-oxo-1-pyrrolidineacetic acid;SY318250;Levetiracetam impurity A;Levetiracetam specified impurity A [EP];IODGAONBTQRGGG-UHFFFAOYSA-N;FT-0652183;2-(2-Oxopyrrolidin-1-yl)butanoic acid, (+/-)-;F96498;FT-0600415;(2R)-2-(2-oxo-1-pyrrolidinyl)butanoic acid;DB-022453;STL451037